SCHEMBL4596569

SCHEMBL4596569

Cc1ccc(S(=O)(=O)OCC(CCc2ccccc2)COS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
CNR2 P34972 8/20 0.48
CYP1A2 P05177 2/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
CA12 O43570 1/20 0.43
CYP3A4 P08684 1/20 0.43
ATM Q13315 1/20 0.43
CA9 Q16790 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MCHR1 Q99705 1/20 0.41
POLB P06746 1/20 0.41
FKBP1A P62942 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2076248 0.86 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL6882711 0.86 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL2076249 0.86 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL2076247 0.86 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL17460433 0.85 CA2 (0.47) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL8165807 0.83 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL8165805 0.83 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL8165802 0.83 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL18857832 0.82 CA2 (0.44) ALDH1A1CNR2CYP1A2BCHEACHE
SCHEMBL6153740 0.81 GAA (0.44) ALDH1A1CYP1A2BCHEACHECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318947-A1 Inhibitors of Akt Activity HEERDING DIRK A 2008-12-25 US disclosed
US-20080318947-A1 Inhibitors of Akt Activity HEERDING DIRK A 2008-12-25 US disclosed
US-20080318947-A1 Inhibitors of Akt Activity HEERDING DIRK A 2008-12-25 US disclosed
EP-1874768-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113837-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318947-A1 Inhibitors of Akt Activity PI4KB, PIK3CA, AKT2 ALDH1A1 4166/4885CNR2 4484/4885CYP1A2 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.